Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Heuser

Showing results (151-160 of 199) with videos related to

Pageof 20
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 2012
Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episodeRichard Musil, Peter Zill, Florian Seemüller, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 26, 2010
Outcomes of 1014 naturalistically treated inpatients with major depressive episodeFlorian Seemüller, Michael Riedel, Michael Obermeier, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on SchizophreniaWolfgang Gaebel, Mathias Riesbeck, Wolfgang Wölwer, et al.
Frontiers in Public Health|February 26, 2021
A Central Clearing Clinic to Provide Mental Health Services for Refugees in GermanyMalek Bajbouj, Patricia Panneck, Sibylle-Maria Winter, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's diseaseOliver Peters, Manuel Fuentes, Lisa Katharina Joachim, et al.
Schizophrenia Research|May 7, 2013
Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on SchizophreniaWolfgang Gaebel, Mathias Riesbeck, Wolfgang Wölwer, et al.
Neurobiology of Aging|December 2, 2014
Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's typeJulius Popp, Steffen Wolfsgruber, Isabella Heuser, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|July 26, 2005
Suicide prevention by lithium SUPLI--challenges of a multi-center prospective studyErik Lauterbach, Bernd Ahrens, Werner Felber, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Akathisia and suicidal ideation in first-episode schizophreniaFlorian Seemüller, Rebecca Schennach, Andreas Mayr, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 3, 2021
The "VIP-ADHD trial": Does brain arousal have prognostic value for predicting response to psychostimulants in adult ADHD patients?Maria Strauß, David Petroff, Jue Huang, et al.
Pageof 20

Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 16, 2012
Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episodeRichard Musil, Peter Zill, Florian Seemüller, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 26, 2010
Outcomes of 1014 naturalistically treated inpatients with major depressive episodeFlorian Seemüller, Michael Riedel, Michael Obermeier, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on SchizophreniaWolfgang Gaebel, Mathias Riesbeck, Wolfgang Wölwer, et al.
Frontiers in Public Health|February 26, 2021
A Central Clearing Clinic to Provide Mental Health Services for Refugees in GermanyMalek Bajbouj, Patricia Panneck, Sibylle-Maria Winter, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's diseaseOliver Peters, Manuel Fuentes, Lisa Katharina Joachim, et al.
Schizophrenia Research|May 7, 2013
Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on SchizophreniaWolfgang Gaebel, Mathias Riesbeck, Wolfgang Wölwer, et al.
Neurobiology of Aging|December 2, 2014
Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's typeJulius Popp, Steffen Wolfsgruber, Isabella Heuser, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|July 26, 2005
Suicide prevention by lithium SUPLI--challenges of a multi-center prospective studyErik Lauterbach, Bernd Ahrens, Werner Felber, et al.
Journal of Clinical Psychopharmacology|August 29, 2012
Akathisia and suicidal ideation in first-episode schizophreniaFlorian Seemüller, Rebecca Schennach, Andreas Mayr, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 3, 2021
The "VIP-ADHD trial": Does brain arousal have prognostic value for predicting response to psychostimulants in adult ADHD patients?Maria Strauß, David Petroff, Jue Huang, et al.
Pageof 20